Sequana Medical N.V. Logo

Sequana Medical N.V.

Develops implantable devices to treat drug-resistant fluid overload from cirrhosis and heart failure.

SEQUA | BR

Overview

Corporate Details

ISIN(s):
BE0974340722
LEI:
8755009AN12Y4PEOII07
Country:
Belgium
Address:
Kortrijksesteenweg 1112 B 102, 9051 Gent
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Sequana Medical N.V. is a commercial-stage medical device company pioneering innovative treatments for drug-resistant fluid overload. The company's lead product is the alfapump®, a proprietary, fully-implanted, and wirelessly charged system that automatically and continuously moves excess abdominal fluid (ascites) to the bladder for natural elimination. The alfapump® is the first U.S. FDA-approved active implantable device for treating recurrent or refractory ascites due to liver cirrhosis, and it also holds a CE mark in Europe. The system is designed to significantly reduce or eliminate the need for invasive therapeutic paracentesis procedures and improve patient quality of life. Sequana Medical is also developing its DSR® (Direct Sodium Removal) therapy platform to manage fluid overload in patients with heart failure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (14 August 2025…
English 289.7 KB
2025-08-14 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (14 August 2025)…
Dutch 317.1 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (ENG).pdf
English 232.0 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (NL).pdf
Dutch 252.2 KB
2025-07-28 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (28 July 2025).…
English 287.8 KB
2025-07-28 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (28 July 2025).p…
Dutch 314.8 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (ENG) (22 July 2025).pdf
English 270.9 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (NL) (22 July 2025).pdf
Dutch 296.4 KB
2025-07-09 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (9 July 2025).p…
English 706.3 KB
2025-07-09 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (9 July 2025).pdf
Dutch 711.7 KB
2025-07-07 18:00
Share Issue/Capital Change
20250707 - Sequana Medical -- Closing Press Release Capital Increase (ENG) .pdf
English 775.4 KB
2025-07-07 18:00
Share Issue/Capital Change
20250707 - Sequana Medical -- Closing Press Release Capital Increase (NL) .pdf
Dutch 781.9 KB
2025-06-26 18:00
Major Shareholding Notification
Sequana Medical -- GRAC Transparency Notification PR (ENG) (26 June 2025).pdf
English 699.5 KB
2025-06-26 18:00
Major Shareholding Notification
Sequana Medical -- GRAC Transparency Notification PR (NL) (26 June 2025).pdf
Dutch 707.1 KB
2025-06-17 18:00
Major Shareholding Notification
Sequana Medical - Belfius Transparency Notification PR (ENG) - (17 June 2025).…
English 700.6 KB

Automate Your Workflow. Get a real-time feed of all Sequana Medical N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sequana Medical N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-06-04 Fin-2K BV Executive member Buy 16,000 N/A
2021-05-27 Crosbie Ian Board Buy 32,000 N/A
2020-09-07 Fin-2K BV Executive member Buy 20,036 N/A
2020-09-04 Crosbie Ian Board Buy 40,073 N/A
2019-06-06 wim ottevaere Board Buy 4,000 25,600.00 EUR
2019-03-29 Fin-2K BV Executive member Buy 20,383 N/A
2019-03-06 Crosbie Ian Board Buy 40,766 N/A
2019-02-26 Chauvineau Pierre Board Buy 10,192 N/A
2019-02-13 wim ottevaere Board Buy 7,000 49,345.10 EUR

Peer Companies

Company Country Ticker View
DAIKEN MEDICAL CO.,LTD Logo
Develops medical devices for anesthesia, infection control, and aspiration systems globally.
Japan 7775
Danish Aerospace Company A/S Logo
Develops advanced medical and exercise equipment for astronauts and space applications.
Denmark DAC
Demant Logo
A global leader in hearing aids, diagnostics, and care for professionals and end-users.
Denmark DEMANT
DENTIS CO.,LTD Logo
Develops dental implants, medical LED lighting, and CAD/CAM solutions for medical professionals.
South Korea 261200
DENTIUM Logo
Global manufacturer of premium dental implant systems and surgical tools for clinicians worldwide.
South Korea 145720
Deversify Health AB Logo
Developed mobile breathalyzers and apps for metabolic health for consumers, businesses & healthcare.
Sweden DEV
Diagonal Bio AB Logo
Developing a platform for ultra-fast, PCR-accurate diagnostics of infectious diseases.
Sweden DIABIO
Dignitana AB Logo
Develops a scalp cooling system for cancer patients to reduce hair loss during chemotherapy.
Sweden DIGN
DIO Corporation Logo
Global medical device company providing dental implants and innovative digital dentistry solutions.
South Korea 039840
DongBang Medical Co., Ltd. Logo
Manufactures devices for oriental medicine & aesthetics, including needles, threads, and fillers.
South Korea 240550

Talk to a Data Expert

Have a question? We'll get back to you promptly.